2nd Quarter - Report

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for ALPHA-1 FOUNDATION

Period 2nd Quarter 2017 Filed Jul 17, 2017 Signed by Katina Pierce

Official filing
Firm
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Client
ALPHA-1 FOUNDATION
Income
$20,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA drug development and clinical trials; Precision Medicine Initiative; American Health Care Act HR 1628, Better Care Reconciliation Act.

LobbyistCovered position, as disclosed
LYLE B DENNIS —
JOHANNA GRAY —
ERIKA MILLER —

Contacted: Natl Institutes of Health (NIH); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1628 (115th)

Medicare/Medicaid MMM

CMS coverage policies - re: oxygen, Medicare reimbursement

LobbyistCovered position, as disclosed
LYLE B DENNIS —
JOHANNA GRAY —
ERIKA MILLER —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); SENATE

Budget/Appropriations BUD

FY 17 Labor-HHS-Appropriations/FY 18 Labor-HHS-Appropriations

LobbyistCovered position, as disclosed
LYLE B DENNIS —
JOHANNA GRAY Intern, Sen. Barack Obama
ERIKA MILLER Intern, Rep. Steve Rothman

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.